UBS AM’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

UBS AM’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-105,861	Closed	-$1.91M	–	2745
2025 Q1	$1.91M	Buy	105,861 +706	+0.7%	+$12.6K	﹤0.01%	2013
2024 Q4	$1.84M	Buy	105,155 +26,705	+34%	+$361K	﹤0.01%	2093
2024 Q3	$903K	Sell	78,450 -21,078	-21%	-$242K	﹤0.01%	2447
2024 Q2	$1.13M	Buy	99,528 +44,797	+82%	+$596K	﹤0.01%	2314
2024 Q1	$784K	Buy	54,731 +20,059	+58%	+$284K	﹤0.01%	2128
2023 Q4	$475K	Hold	34,672	–	–	﹤0.01%	2335
2023 Q3	$282K	Hold	34,672	–	–	﹤0.01%	2450
2023 Q2	$277K	Hold	34,672	–	–	﹤0.01%	2495
2023 Q1	$277K	Sell	34,672 -21,956	-39%	-$226K	﹤0.01%	2495
2022 Q4	$643K	Buy	56,628 +19,902	+54%	+$217K	﹤0.01%	2069
2022 Q3	$321K	Buy	+36,726	New	+$381K	﹤0.01%	2479

UBS AM's PTVE Position: Q2 2025 in Review

UBS AM sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 105,861 shares — an estimated $1.91M sold.

UBS AM first reported a position in PTVE in Q3 2022 and held it in 11 quarters. The position peaked at $1.91M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

UBS AM reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
UBS AM sold 105,861 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.91M.
UBS AM first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2022 and held it in 11 quarters.
UBS AM's Pactiv Evergreen Inc. Common stock position peaked at $1.91M in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.